Early Electrophysiological Abnormalities and Clinical Neuropathy
Open Access
- 14 September 2013
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 36 (10), 3187-3194
- https://doi.org/10.2337/dc12-2226
Abstract
OBJECTIVE The aim of this study was to elucidate whether subclinical nerve dysfunction as reflected by neurophysiological testing predicts the development of clinical neuropathy in patients with type 1 diabetes. RESEARCH DESIGN AND METHODS Fifty-nine patients were studied twice with neurophysiological measurements at baseline and at follow-up. At baseline, patients were 15.5 ± 3.22 years (range 7–22 years) of age, and duration of diabetes was 6.8 ± 3.3 years. At follow-up, patients were 20–35 years of age, and disease duration was 20 ± 5.3 years (range 10–31 years). RESULTS At baseline, patients showed modestly reduced nerve conduction velocities and amplitudes compared with healthy subjects, but all were free of clinical neuropathy. At follow-up, clinical neuropathy was present in nine (15%) patients. These patients had a more pronounced reduction in peroneal motor nerve conduction velocity (MCV), median MCV, and sural sensory nerve action potential at baseline (P < 0.010–0.003). In simple logistic regression analyses, the predictor with the strongest association with clinical neuropathy was baseline HbA1c (R2 = 48%, odds ratio 7.9, P < 0.002) followed by peroneal MCV at baseline (R2 = 38%, odds ratio 0.6, P < 0.006). With the use of a stepwise forward analysis that included all predictors, first baseline HbA1c and then only peroneal MCV at baseline entered significantly (R2 = 61%). Neuropathy impairment assessment showed a stronger correlation with baseline HbA1c (ρ = 0.40, P < 0.002) than with follow-up HbA1c (ρ = 0.034, P < 0.007). CONCLUSIONS Early defects in nerve conduction velocity predict the development of diabetic neuropathy. However, the strongest predictor was HbA1c during the first years of the disease.Keywords
This publication has 30 references indexed in Scilit:
- Intensive Diabetes Therapy and Glomerular Filtration Rate in Type 1 DiabetesThe New England Journal of Medicine, 2011
- Modeling nerve conduction criteria for diagnosis of diabetic polyneuropathyMuscle & Nerve, 2011
- Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and TreatmentsDiabetes Care, 2010
- Effect of Prior Intensive Therapy in Type 1 Diabetes on 10-Year Progression of Retinopathy in the DCCT/EDIC: Comparison of Adults and AdolescentsDiabetes, 2010
- 10-Year Follow-up of Intensive Glucose Control in Type 2 DiabetesThe New England Journal of Medicine, 2008
- Subclinical Neuropathy Among Diabetes Control and Complications Trial Participants Without Diagnosable Neuropathy at Trial CompletionDiabetes Care, 2007
- Normal values of nerve conduction in children and adolescentsElectroencephalography and Clinical Neurophysiology/Electromyography and Motor Control, 1995
- Normal values of nerve conduction in children and adolescentsElectroencephalography and Clinical Neurophysiology, 1995
- Graded assessment and classification of impaired temperature sensibility in patients with diabetic polyneuropathy.Journal of Neurology, Neurosurgery & Psychiatry, 1991
- Variations in motor conduction velocity produced by acute changes of the metabolic state in diabetic patientsDiabetologia, 1968